AGRN and sarcopenia: This hypothesis is supported by studies that demonstrate an overexpression of neurotrypsin to invoke severe NMJ fragmentation and premature sarcopenia in mice [26, 27], and another demonstrating that an injection of neurotrypsin-resistant agrin reverses many sarcopenic characteristics in mice over-expressing neurotrypsin [28].